“Design, Molecular Docking, and Pharmacokinetic Evaluation of Naproxen-Based 2‑Azetidinone Derivatives for Cancer Treatment” (2026) Al Mustansiriyah Journal of Pharmaceutical Sciences, 26(1), pp. 22–37. doi:10.32947/ajps.v26i1.1344.